Board of Directors

 
Nominating & Corporate Governance Committee
Compensation Committee
Audit Committee
Dan Swisher
Chair of Board

Chief Executive Officer,
Sunesis Pharmaceuticals, Inc.
Member
--
Member
Timothy B. Anderson
Former Senior Vice President,
Baxter International Inc.
Chair
--
Member
Senior Vice President & Chief Medical Officer
and Chief Scientific Officer
--
--
--
Bruce C. Cozadd
Chairman & Chief Executive Officer,
Jazz Pharmaceuticals, plc
--
Member
Chair
President & Chief Executive Officer
--
--
--
Gail Schulze
Former Chairman, Zosano Pharma
--
Chair
--
President & Chief Executive Officer,
Affymetrix, Inc.
--
Member
--


Dan Swisher
  -  Mr. Swisher has served as a member of our Board since June 2011.  He was elected as Chairman of the Board in October 2013. He has served as chief executive officer and member of the Board of Sunesis Pharmaceuticals, Inc. since 2003, and as Sunesis' president since 2005. Mr. Swisher joined Sunesis in 2001, previously serving as chief business officer and chief financial officer. Prior to joining Sunesis, he served in various management roles, including senior vice president of sales and marketing for ALZA Corporation from 1992 to 2001. He holds a B.A. in History from Yale University and an M.B.A. from the Stanford Graduate School of Business.

Timothy B. Anderson  -  Mr. Anderson has served as a member of our Board since 2003. He was Senior Vice President of Strategy and Business Development of Baxter International, Inc., a pharmaceutical company, from 1999 until 2002, and held various management positions at Baxter International from 1992 to 1999, including President, Biotech Group from 1992 until 1997, Group Vice President from 1993 until 1997 and Chairman, Baxter Europe from 1997 until 1999. Mr. Anderson is currently a director of Lake Forest Hospital and a member of the Scientific Advisory Board of Baxter International.

Laurence M. Corash, M.D.  -  Dr. Corash, one of our co-founders, has served as a member of our Board since December 2002. He was appointed Chief Scientific Officer in 2009, and has held various medical positions within the company, including Chief Medical Officer, since 1994. Dr. Corash was a consultant to us from 1991 to 1994. He has been a Professor of Laboratory Medicine at the University of California, San Francisco since July 1985 and was Chief of the Hematology Laboratory for the Medical Center at the University of California, San Francisco from 1982 to 1997. From February 1990 to July 1994, Dr. Corash was a consultant to the FDA Advisory Panel for Hematology Devices. He currently serves on the U.S. Health and Human Services' Advisory Committee on Blood Safety and Availability.

Bruce C. Cozadd  -  Mr. Cozadd has served as a member of our Board since November 2001. He serves as Chairman and Chief Executive Officer of Jazz Pharmaceuticals, a pharmaceutical company that he co-founded in 2003. Mr. Cozadd was Executive Vice President and Chief Operating Officer of ALZA Corporation, a pharmaceutical company, from 2000 until 2001, and held various management positions at ALZA from 1991 to 2000, including Senior Vice President and Chief Financial Officer. Previously, he was a member of the health care investment banking team at Smith Barney, Harris Upham & Co. Mr. Cozadd currently serves on the boards of Threshold Pharmaceuticals and The Nueva School, a non-profit institution.

William 'Obi' Greenman  -  Mr. Greenman was named our President and Chief Executive Officer in April 2011. He had been Cerus' Chief Business Officer since April 2010. Previously, he was senior vice president, business development and marketing. From 2006 to 2008, he held the position of president, Cerus Europe, and prior to that, he served as vice president, business development. Prior to joining Cerus in 1995 as director of business development, he worked in various marketing and business development positions in Baxter's Biotech Division from 1991 to 1995.  Mr. Greenman currently is a member of the Board of Directors of Aduro Biotech. He received  his B.A.S. in Economics and Biological Sciences from Stanford University..

Gail Schulze  -  Ms. Schulze has served as a member of our Board since October 2007. She is the former Chairman of Zosano Pharma, a private late-stage transdermal drug delivery company. Prior to joining Zosano, she was CEO of YM Biosciences US and president, YM Biosciences, Inc., a global biopharmaceutical organization. Prior to joining YM Biosciences in 2006, she was president, CEO and director of Eximias Pharmaceutical Corporation. From 2001 to 2004, Ms. Schulze was COO and deputy CEO of Aventis Behring LLC, an independent biologics subsidiary of Aventis, and from 1997 to 2001, was senior executive vice president and chief commercial officer. From 1996 to 1997 she was corporate vice president of Allegiance Healthcare Corporation and from 1979 to 1996 Ms. Schulze held multiple positions within Baxter Healthcare Corporation, most recently as president of the US Managed Care division and president of Renal Division Europe.  Ms. Schulze has served on multiple private and public boards of companies focusing on medical technology and chronic therapy market development.

Frank Witney - Frank Witney, Ph.D., has served as a member of our Board since March 2014. Mr. Witney has served as President, Chief Executive Officer and a director of Affymetrix, Inc. since July 2011. Dr. Witney served as President and Chief Executive Officer of Dionex Corporation from April 2009 to May 2011. Between December 2008 and April 2009, Dr. Witney served as Affymetrix’ Executive Vice President and Chief Commercial Officer. Prior to that, Dr. Witney served as President and Chief Executive Officer of Panomics, Inc. from July 2002 to December 2008.  Dr. Witney was a post-doctoral fellow at the National Institutes of Health and holds a Ph.D. in Molecular and Cellular Biology and an M.S. in Microbiology from Indiana University, and B.S. in Microbiology from the University of Illinois.

  • Global Headquarters

  • 2550 Stanwell Drive
    Concord, CA US 94520
    +1 925.288.6000
  • European Headquarters

  • Stationsstraat 79-D
    3811 MH Amersfoort, Netherlands
    +31 (0) 33 49 60 600